Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
The Urologic Clinics of North America|November 29, 2015
MicroRNAs in Testicular Cancer Diagnosis and PrognosisHui Ling, Lisa Krassnig, Marc D Bullock, et al.Biology of the Cell|December 23, 2011
MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progressionMarc D Bullock, Abdulkadir E Sayan, Graham K Packham, et al.International Journal of Molecular Sciences|November 12, 2015
Long Non-Coding RNAs in Endometrial CarcinomaMaria A Smolle, Marc D Bullock, Hui Ling, et al.Anticancer Research|October 28, 2015
Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and FutureMichael Stotz, Armin Gerger, Johannes Haybaeck, et al.Cancer Letters|February 10, 2018
Exosomal microRNAs (exomiRs): Small molecules with a big role in cancerRahul Bhome, Filippo Del Vecchio, Gui-Han Lee, et al.Frontiers in Cell and Developmental Biology|June 16, 2015
A top-down view of the tumor microenvironment: structure, cells and signalingRahul Bhome, Marc D Bullock, Hajir A Al Saihati, et al.Non-Coding RNA|June 5, 2018
Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in CancerMarc D Bullock, Andreia M Silva, Pinar Kanlikilicer-Unaldi, et al.Journal of Visualized Experiments : Jove|May 20, 2014
Molecular profiling of the invasive tumor microenvironment in a 3-dimensional model of colorectal cancer cells and ex vivo fibroblastsMarc D Bullock, Max Mellone, Karen M Pickard, et al.Oncotarget|March 20, 2015
Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAsMarc D Bullock, Karen Pickard, Richard Mitter, et al.Cancer Research|August 17, 2013
miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistanceLei Zhang, Karen Pickard, Veronika Jenei, et al.Pageof 2